We are pleased to share Wellnex Life (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently released a key ASX announcement.
Wellnex Life Limited (ASX: WNX) (“Wellnex” or “the Company”) is pleased to announce that it has successfully been admitted to the AIM market of the London Stock Exchange (LSE) with effect from market open on Friday 21 March 2025 (UK time).
Announcement Highlights
- Wellnex Life commenced trading on the AIM market of the London Stock Exchange on market open on Friday 21 March 2025 (UK time)
- Deferred consideration for Pain Away acquisition fully settled
- Completion of a successful capital raising through a placing of new Ordinary Shares with certain institutional and other investors through a UK and Australian placing
- First day of dealings announcement issued on the Company’s admission to the AIM Market
Wellnex Life's Joint Managing Director Zack Bozinovski said:
“ We are delighted with the support we’ve received from both Australian and UK investors to provide us with the funding needed to eliminate costly debt, and provide us with the balance sheet strength to expand our existing business organically and launch our products into the European market. We have an opportunity to capitalise on a growing consumer healthcare market and are well positioned to grow globally, as already evidenced by our recent launch of products in the UK under our supply agreement with Haleon.
In our latest trading update for January and February we recorded an 89% year-on-year growth across both own Brand sales and IP licensing revenues. We recorded a 45% increase in gross margins for the two-month period. We expect that our UK IPO, and support from UK investors, along with the support from our Australian investors, provides us with a strong foundation for further growth and geographic expansion. "
Congratulations to George Karafotias, Zack Bozinovski, the board and the team at Wellnex Life for reaching this significant milestone.
Read the full Wellnex Life ASX announcement here.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.
